Drug intelligence / Profile preview

oxycodone + ciprofol

Development stage
Unknown
Lead developer
Haisco Pharmaceutical Group
Modality
Small Molecules
Administration
Intravenous
01

Overview

The combination of oxycodone and ciprofol is an anesthetic regimen primarily investigated for use in painless artificial abortion procedures. Ciprofol (HSK3486) is a novel intravenous anesthetic agent and a GABAA receptor agonist, developed as an alternative to propofol with a higher potency and potentially improved safety profile, including reduced injection pain and respiratory depression. Oxycodone is a semi-synthetic opioid agonist that acts primarily on mu-opioid receptors to provide potent analgesia. When used together, oxycodone provides preemptive analgesia, which allows for a reduction in the required dose of ciprofol, thereby enhancing the quality of anesthesia and reducing the incidence of adverse events such as respiratory depression and hemodynamic instability during short surgical procedures like artificial abortion.

Other names
oxycodone hydrochloride + ciprofol
02

Targets

GABRA2 (Gamma-aminobutyric acid receptor subunit alpha 2)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on oxycodone + ciprofol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxycodone + ciprofol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call